Signaling networks assembled by oncogenic EGFR and c-Met

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 2, 2008, Pages 692-697

  Guo, Ailan ^a   Villén, Judit ^b   Kornhauser, Jon ^a   Lee, Kimberly A ^a   Stokes, Matthew P ^a   Rikova, Klarisa ^a   Possemato, Anthony ^a   Nardone, Julie ^a   Innocenti, Gregory ^a   Wetzel, Randall ^a   Wang, Yi ^a   MacNeill, Joan ^a   Mitchell, Jeffrey ^a   Gygi, Steven P ^b   Rush, John ^a   Polakiewicz, Roberto D ^a   Comb, Michael J ^a  

^a CELL SIGNALING TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

c Met; EGF receptor; Oncogene dependence; Proteomics; Stable isotope labeling with amino acids in cell culture

Indexed keywords

EPIDERMAL GROWTH FACTOR; GEFITINIB; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; PHOSPHOTYROSINE; SCATTER FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; ONCOGENE; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PHOSPHOTYROSINE; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-MET; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 38649119730     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0707270105     Document Type: Article

References (31)

1. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, et al. (2004) N Engl J Med 350:2129-2139.
2. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et al. (2004) Science 304:1497-1500.
3. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, et al. (2004) Proc Natl Acad Sci USA 101:13306-13311.
4. Smolen GA, Sordella R, Muir B, Mohapatra G, Barmettler A, Archibald H, Kim WJ, Okimoto RA, Bell DW, Sgroi DC, et al. (2006) Proc Natl Acad Sci USA 103:2316-2321.
5. Riely GJ, Politi KA, Miller VA, Pao W (2006) Clin Cancer Res 12:7232-7241.
6. Yun CH, Boggon TJ, Li Y, Woo MS, Greulich H, Meyerson M, Eck MJ (2007) Cancer Cell 11:217-227.
7. Mulloy R, Ferrand A, Kim Y, Sordella R, Bell DW, Haber DA, Anderson KS, Settleman J (2007) Cancer Res 67:2325-2330.
8. Sordella R, Bell DW, Haber DA, Settleman J (2004) Science 305:1163-1167.
9. Sharma SV, Gajowniczek P, Way IP, Lee DY, Jiang J, Yuza Y, Classon M, Haber DA, Settleman J (2006) Cancer Cell 10:425-435.
10. Weinstein B (2002) Science 297:63-64.
11. Blagoev B, Ong SE, Kratchmarova I, Mann M (2004) Nat Biotechnol 22:1139-1145.
12. Thelemann A, Petti F, Griffin G, Iwata K, Hunt T, Settinari T, Fenyo D, Gibson N, Haley JD (2005) Mol Cell Proteomics 4:356-376.
13. Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, Lauffenburger DA, White FM (2005) Mol Cell Proteomics 4:1240-1250.
14. Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha XM, Polakiewicz RD, Comb MJ (2005) Nat Biotechnol 23:94-101.
15. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA, Ahn NG (2005) Mol Cell Proteomics 4:1487-1502.
16. Pao W, Wang TY, Riely GJ, Miller VA, Pan Q, Ladanyi M, Zakowski MF, Heelan RT, Kris MG, Varmus HE (2005) PLoS Med 2:e17.
17. Soung YH, Lee JW, Kim SY, Seo SH, Park WS, Nam SW, Song SY, Han JH, Park CK, Lee JY, et al. (2005) Virchows Arch 446:483-488.
18. Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson BE, Cantley LC (2005) Proc Natl Acad Sci USA 102:3788-3793.
19. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, et al. (2005) N Engl J Med 353:2012-2024.
20. Ferby I, Reschke M, Kudlacek O, Knyazev P, Pante G, Amann K, Sommergruber W, Kraut N, Ullrich A, Fassler R, Klein R (2006) Nat Med 12:568-573.
21. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Mol Cell Proteomics 1:376-386.
22. Fanning AS, Anderson JM (1998) Curr Top Microbiol Immunol 228:209-233.
23. Garner CC, Nash J, Huganir RL (2000) Trends Cell Biol 10:274-280.
24. Wang X, Le P, Liang C, Chan J, Kiewlich D, Miller T, Harris D, Sun L, Rice A, Vasile S, et al. (2003) Mol Cancer Ther 2:1085-1092.
25. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, et al. (2007) Science 316:1039-1043.
26. Godin-Heymann N, Bryant I, Rivera MN, Ulkus L, Bell DW, Riese DJ, II, Settleman J, Haber DA (2007) Cancer Res 67:7319-7326.
27. Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG, Varmus H (2005) PLoS Med 2:e73.
28. Kwak EL, Sordella R, Bell DW, Godin-Heymann N, Okimoto RA, Brannigan BW, Harris PL, Driscoll DR, Fidias P, Lynch TJ, et al. (2005) Proc Natl Acad Sci USA 102:7665-7670.
29. Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R, Stegh AH, Bradner JE, Ligon KL, Brennan C, et al. (2007) Science 318:287-290.
30. Neher SB, Villen J, Oakes EC, Bakalarski CE, Sauer RT, Gygi SP, Baker TA (2006) Mol Cell 22:193-204.
31. Hornbeck PV, Chabra I, Kotrhauser JM, Skrzypek E, Zhang B (2004) Proteomics 4:1551-1561.